A detailed history of Deutsche Bank Ag\ transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 32,370 shares of SUPN stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,370
Previous 25,659 26.15%
Holding current value
$1.28 Million
Previous $686,000 47.08%
% of portfolio
0.0%
Previous 0.0%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$25.77 - $35.16 $172,942 - $235,958
6,711 Added 26.15%
32,370 $1.01 Million
Q2 2024

Aug 14, 2024

SELL
$25.99 - $33.85 $137,591 - $179,201
-5,294 Reduced 17.1%
25,659 $686,000
Q1 2024

May 15, 2024

BUY
$27.11 - $35.17 $116,789 - $151,512
4,308 Added 16.17%
30,953 $1.06 Million
Q4 2023

Feb 14, 2024

SELL
$22.72 - $29.68 $14,972 - $19,559
-659 Reduced 2.41%
26,645 $771,000
Q3 2023

Nov 09, 2023

BUY
$27.57 - $32.91 $84,970 - $101,428
3,082 Added 12.72%
27,304 $752,000
Q2 2023

Aug 14, 2023

SELL
$29.91 - $38.73 $290,456 - $376,107
-9,711 Reduced 28.62%
24,222 $728,000
Q1 2023

May 15, 2023

BUY
$34.93 - $42.03 $324,255 - $390,164
9,283 Added 37.66%
33,933 $1.23 Million
Q4 2022

Feb 13, 2023

BUY
$31.09 - $37.88 $77,818 - $94,813
2,503 Added 11.3%
24,650 $879,000
Q3 2022

Nov 14, 2022

SELL
$28.79 - $35.41 $1.25 Million - $1.54 Million
-43,567 Reduced 66.3%
22,147 $749,000
Q2 2022

Aug 11, 2022

SELL
$25.33 - $34.25 $4.15 Million - $5.62 Million
-163,970 Reduced 71.39%
65,714 $1.9 Million
Q1 2022

May 13, 2022

SELL
$28.51 - $32.9 $1.54 Million - $1.78 Million
-53,991 Reduced 19.03%
229,684 $7.42 Million
Q4 2021

Feb 11, 2022

BUY
$26.37 - $34.22 $731,108 - $948,749
27,725 Added 10.83%
283,675 $8.27 Million
Q3 2021

Nov 04, 2021

SELL
$23.54 - $31.39 $2.68 Million - $3.57 Million
-113,678 Reduced 30.75%
255,950 $6.83 Million
Q2 2021

Aug 11, 2021

BUY
$26.72 - $33.19 $3.1 Million - $3.84 Million
115,840 Added 45.64%
369,628 $11.4 Million
Q1 2021

May 13, 2021

BUY
$24.15 - $31.45 $114,060 - $148,538
4,723 Added 1.9%
253,788 $6.64 Million
Q4 2020

Feb 16, 2021

BUY
$17.7 - $25.81 $753,135 - $1.1 Million
42,550 Added 20.6%
249,065 $6.27 Million
Q3 2020

Nov 12, 2020

SELL
$20.2 - $25.05 $1.38 Million - $1.71 Million
-68,390 Reduced 24.88%
206,515 $4.3 Million
Q2 2020

Aug 13, 2020

BUY
$17.09 - $24.89 $2.52 Million - $3.67 Million
147,445 Added 115.68%
274,905 $6.53 Million
Q1 2020

May 14, 2020

SELL
$14.45 - $24.69 $3.59 Million - $6.14 Million
-248,610 Reduced 66.11%
127,460 $2.29 Million
Q4 2019

Feb 14, 2020

BUY
$19.93 - $29.13 $268,058 - $391,798
13,450 Added 3.71%
376,070 $8.92 Million
Q3 2019

Nov 14, 2019

SELL
$25.47 - $33.37 $1.82 Million - $2.38 Million
-71,377 Reduced 16.45%
362,620 $9.96 Million
Q2 2019

Aug 14, 2019

SELL
$29.96 - $38.87 $832,109 - $1.08 Million
-27,774 Reduced 6.01%
433,997 $14.4 Million
Q1 2019

May 15, 2019

SELL
$32.77 - $41.99 $1.16 Million - $1.48 Million
-35,344 Reduced 7.11%
461,771 $16.2 Million
Q4 2018

Feb 14, 2019

SELL
$30.84 - $49.51 $3.5 Million - $5.63 Million
-113,641 Reduced 18.61%
497,115 $16.5 Million
Q3 2018

Dec 21, 2021

BUY
$42.7 - $56.55 $1.84 Million - $2.44 Million
43,186 Added 7.61%
610,756 $30.8 Million
Q3 2018

Nov 14, 2018

SELL
$42.7 - $56.55 $10.2 Million - $13.5 Million
-238,331 Reduced 29.57%
567,570 $28.6 Million
Q2 2018

Apr 21, 2020

BUY
$44.1 - $59.85 $5 Million - $6.79 Million
113,435 Added 16.38%
805,901 $48.2 Million
Q2 2018

Aug 14, 2018

BUY
$44.1 - $59.85 $21 Million - $28.5 Million
476,695 Added 220.93%
692,466 $41.4 Million
Q1 2018

Oct 18, 2019

BUY
$37.15 - $46.9 $5.19 Million - $6.55 Million
139,735 Added 183.77%
215,771 $9.88 Million
Q1 2018

May 15, 2018

SELL
$37.15 - $46.9 $3.87 Million - $4.89 Million
-104,197 Reduced 57.81%
76,036 $3.48 Million
Q4 2017

Feb 14, 2018

SELL
$36.4 - $42.6 $5.77 Million - $6.75 Million
-158,459 Reduced 46.79%
180,233 $7.18 Million
Q3 2017

Nov 14, 2017

BUY
$36.75 - $49.65 $12.4 Million - $16.8 Million
338,692
338,692 $13.5 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $2.11B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.